FDA-approved AI tool Clairity Breast rolls out nationwide to predict five-year breast cancer risk at $249 per scan
elonmusk · x · 2026-10-02
Digital health company Everlywell is rolling out Clairity Breast nationwide: an FDA-approved AI tool that analyzes a single mammogram to predict a woman's five-year breast cancer risk as a 0-100 probability score, rather than detecting existing tumors. Previously limited to select sites in Massachusetts and Colorado, it now costs $249 out of pocket and is not covered by insurance. The NYT profiles a 65-year-old patient who took preventive steps after an AI-flagged elevated risk. Elon Musk amplified the story, arguing that in the near future it will be considered malpractice not to run every X-ray, lab report and blood panel through an LLM, and that patients will do it themselves with personal models, saving millions of lives.
More from Apps
- User builds interactive 3D molecular viewer macOS app with GPT-6.2 Astra — DeryaTR_ · 2026-11-19
- Google employee replaces doomscrolling with 3 fully automated personal AI newsletters — DynamicWebPaige · 2026-11-19
- Scale AI's Alexandr Wang Launches Virtual Try-On Shopping Feature in Muse App — alexandr_wang · 2026-11-19
- Open-source MCP server controls Logitech Harmony hubs locally with LLM-safe guardrails — SDNick484 · 2026-11-19
- AWS case study: Social Department's QuickSearch finds memeable moments across video libraries — AWS ML Blog · 2026-11-19
- Tesla Cybercab spotted operating outside its Orlando service area in Celebration, Florida — walkingriver · 2026-11-19